To determine if the regulation of proapoptotic genes by DOT1L is clinically relevant, we checked whether the proapoptotic genes that were upregulated as a result of EPZ-5676 treatment in the ovarian cancer cell lines were repressed in ovarian tumor samples in which DOT1L was overexpressed. This evidence concerns the gene DOT1L and ovarian neoplasm.